OIP5 Monoclonal antibody, PBS Only

• 

  WB analysis using 66461-1-Ig (same clone as 66461-1-PBS)

  Various lysates were subjected to SDS PAGE followed by western blot with 66461-1-Ig (OIP5 antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 66461-1-PBS in a different storage buffer formulation.

• 

  WB analysis of Jurkat using 66461-1-Ig (same clone as 66461-1-PBS)

  WB result of OIP5 antibody (66461-1-Ig; 1:400; incubated at room temperature for 1.5 hours) with sh-Control and sh-OIP5 transfected Jurkat cells. This data was developed using the same antibody clone with 66461-1-PBS in a different storage buffer formulation.

• Featured Product
• KD/KO Validated

OIP5 Monoclonal Antibody for WB, Indirect ELISA

Cat No. 66461-1-PBS

Clone No.1E9B5

Host / Isotype

Mouse / IgG2b

Reactivity

human

Applications

WB, Indirect ELISA

Synonyms

5730547N13Rik, Cancer/testis antigen 86, CT86, LINT 25, MIS18B, MIS18beta, OIP 5, OIP5, Opa interacting protein 5, Protein Mis18 beta

---

Product Information

66461-1-PBS targets OIP5 in WB, Indirect ELISA applications and shows reactivity with human samples.

• Tested Reactivity: human
• Host / Isotype: Mouse / IgG2b
• Class: Monoclonal
• Type: Antibody
• Immunogen: OIP5 fusion protein Ag2790
• Full Name: Opa interacting protein 5
• Calculated Molecular Weight: 229 aa, 25 kDa
• Observed Molecular Weight: 25-30 kDa
• GenBank Accession Number: BC015050
• Gene Symbol: OIP5
• Gene ID (NCBI): 11339
• RRID: AB_2881830
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Protein A purification
• UNIPROT ID: O43482
• Storage Buffer: PBS Only
• Storage Conditions: Store at -80°C.

Background Information

OIP5, also named as IS18B and CT86, is required for recruitment of CENPA to centromeres and normal chromosome segregation during mitosis. It is over expressed in the majority of primary lung and esophageal cancers. OIP5 is a promising target for developing new prognostic biomarkers and anti-cancer drugs.